March 18, 2020 / 12:04 AM / 12 days ago

Facing uproar, patent holder clarifies case against COVID-19 test maker

In an apparent effort to quell backlash, an entity holding patents originally awarded to disgraced blood testing startup Theranos on Tuesday issued a press release clarifying its demands in a recent infringement case against a company developing a COVID-19 test.

Labrador Diagnostics LLC, an entity holding Theranos patents backed by hedge fund Fortress Investment Group, said in the press release that its March 9 infringement complaint against bioMérieux Inc “focuses on activities over the past six years that are not in any way related to COVID-19 testing.”

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below